DRG Epidemiology's coverage of type 1 diabetes comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the diagnosed incidence and diagnosed prevalence of type 1 diabetes for each country, as well as annualized case counts projected to the national population.

Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets and 10 years for the other countries covered in this report.

DRG Epidemiology's type 1 diabetes forecast will answer the following questions:

  • Of all people with type 1 diabetes, how many in each of the major mature pharmaceutical markets are drug-treated?
  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of type 1 diabetes over the forecast period?

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

DRG Epidemiology provides at least ten years of forecast data for the following type 1 diabetes patient populations:

  • Diagnosed prevalent cases.
  • Diagnosed prevalent cases by drug treatment.
  • Diagnosed incident cases.
  • Lifetime DALYs gained.

Note: Coverage may vary by country and region.

Table of contents

  • Type 1 Diabetes - Epidemiology - Epidemiology Dashboard
    • Introduction
      • Epidemiology Dashboard

Author(s): Joseph Granato, M.P.H.; Nicole Zhang, M.P.H.

Joseph Granato, M.P.H., is a senior epidemiologist at DRG, part of Clarivate. Before joining DRG, he worked with the Monroe County Health Department on the surveillance of reportable diseases, including dengue fever. He received his M.P.H. from Des Moines University, where he worked on several population health projects, including tick-borne diseases. He also holds a B.S. in animal science from the University of Tennessee.

Nicole Zhang, M.P.H., is an epidemiologist at DRG, part of Clarivate. Prior to joining DRG, she worked as a research analyst at Massachusetts General Hospital, where she independently managed data from a food information survey conducted in Chelsea, Massachusetts. She has also worked for the Massachusetts Department of Public Health, conducting secondary research in the field of gestational diabetes. She holds an M.P.H. from Tufts Medical School, where she specialized in epidemiology and biostatistics. She also holds a B.A. in chemistry and statistics from Mount Holyoke College.


Related Reports

Type 1 Diabetes - Landscape & Forecast - Disease Landscape & Forecast

The number of treatment options continues to increase in the T1D space. Existing agents fail to provide sustained and intrinsic control of

View Details

Type 1 Diabetes - Epidemiology - Mature Markets

DRG Epidemiology's coverage of type 1 diabetes comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence of type 1 di...

View Details